PSA Density and Lesion Volume: Key Factors in Avoiding Unnecessary Biopsies for PI‐RADS 3 Lesions

Documenti analoghi

• The Effects of the Blood‐Based S2,3PSA% Test on Prostate Cancer Screening: A Novel Approach to Reduce the Need for MRI and Unnecessary Biopsies
  di: Hikari Miura, et al.
  Pubblicazione: (2025)
• Individualized Precision Prostate Biopsy Strategy for Patients With PI‐RADS Score 2: A Retrospective Multicenter Study
  di: Zhiyao Xu, et al.
  Pubblicazione: (2025)
• Diagnostic Performance of the Novel Biomarker S2,3PSA Density for Prostate Biopsy Optimization in Prostate Imaging Reporting and Data System 3–5 Lesions
  di: Takanori Tokunaga, et al.
  Pubblicazione: (2025)
• The Role of Secondary Lesion Biopsy in Detecting Clinically Significant Prostate Cancer
  di: Trevor C. Hunt, et al.
  Pubblicazione: (2025)
• Combining Prostate‐Specific Antigen Density With PI‐RADS to Improve the Detection of Clinically Significant Prostate Cancer at MRI/TRUS Fusion‐Targeted Re‐Biopsy
  di: Yuto Ono, et al.
  Pubblicazione: (2025)